The Patent Finder

Harpoon Therapeutics, Inc.

Also on record
Records under this name other than the patents Harpoon Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 23 patents it holds.

Showing 1 to 5 of 5 · Back to Harpoon Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,208,285Compositions and Methods for TCR Reprogramming Using Fusion Proteins
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,085,021Compositions and Methods for TCR Reprogramming Using Fusion Proteins
Formerly held
Lapsed on the fee record
Ended Aug 10, 2025 · High confidence
Lapsed on the fee recordEnded Aug 10, 2025High confidence
US 10,849,973Prostate specific membrane antigen binding protein
Lapsed on the fee record
Ended Dec 1, 2024 · USPTO record
Lapsed on the fee recordEnded Dec 1, 2024USPTO record
US 10,844,134PSMA targeting trispecific proteins and methods of use
Lapsed on the fee record
Ended Nov 24, 2024 · USPTO record
Lapsed on the fee recordEnded Nov 24, 2024USPTO record
US 10,730,954MSLN targeting trispecific proteins and methods of use
Lapsed on the fee record
Ended Aug 4, 2024 · USPTO record
Lapsed on the fee recordEnded Aug 4, 2024USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited